Primary Record
physostigmine
- In stock
- 3,383 g
- Purity
- 99.7 %
- CAS
- 57-47-6
Compound Identifiers & Properties
- CAS
- 57-47-6
- PubChem CID
- 5983
- SMILES
- C[C@@]12CCN([C@@H]1N(C3=C2C=C(C=C3)OC(=O)NC)C)C
- Canonical SMILES
- CNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(C)[C@@H]1N2C
Names & Synonyms
- physostigmine
- Eserine
- Physostol
- Antilirium
- Esromiotin
- Ezerin
- (-)-physostigmine
- Calabarine
- Fysostigmin
- Erserine
- cogmine
- eserin
- Eserinum
- Eserine sulfate
- 57-47-6
- physostigmin
- Xalieve
- Isopto Eserine
- Fysostigmin [Czech]
- Eserine salicylate
- Eserine[alkaloid]
- Physostigmine salicylate
- (-) physostigmine
- Eserine (TN)
- Physostigmine (USP)
- CHEMBL94
- Eserolein, methylcarbamate
- Physostigmine free base
- Spectrum_000916
- Spectrum_001789
- Physostigmine [USP:BAN]
- Eserine hemisulfate salt
- RCRA waste no. P204
- ESERINUM [HPUS]
- RefChem:56714
- SpecPlus_000381
- DTXSID3023471
- Eserolein, methylcarbamate (ester)
- Physostigmine [USAN:BAN]
- AC1L1LJL
- Prestwick0_000566
- Prestwick1_000566
- Prestwick2_000566
- Prestwick3_000566
- Spectrum2_000330
- Spectrum2_000757
- Spectrum2_001283
- Spectrum3_000545
- Spectrum3_000901
- Spectrum4_000997
- Spectrum4_001631
- Spectrum4_001913
- Spectrum5_000441
- Spectrum5_000626
- Spectrum5_001672
- 9U1VM840SP
- CCRIS 3422
- ESERINE HEMISULFATE
- UNII-9U1VM840SP
- PHYSOSTIGMINE [MI]
- D09JVV
- HSDB 3161
- MCV 4484
- MCV-4484
- physostigmine.salicylic acid
- DTXCID603471
- PIJVFDBKTWXHHD-HIFRSBDPSA-N
- C15H21N3O2
- PHYSOSTIGMINE [HSDB]
- Lopac0_000483
- NIH 10421
- NSC-30782
- SCHEMBL24044
- BSPBio_000352
- BSPBio_002189
- KBioGR_001433
- KBioGR_002061
- KBioGR_002533
- KBioSS_001396
- KBioSS_002279
- PHYSOSTIGMINE [VANDF]
- CHEBI:27953
- MLS001304022
- NSC30782
- orb104785
- DivK1c_006477
- PHYSOSTIGMINE [MART.]
- SPECTRUM1500753
- EINECS 200-332-8
- SPBio_000339
- SPBio_000774
- SPBio_001285
- SPBio_002571
- NSC 30782
- PHYSOSTIGMINE [WHO-DD]
- BPBio1_000388
- CHEMBL537674
- cid_657348
- GTPL6598
- MEGxp0_001872
- SCHEMBL29482277
- ACon1_000097
- BDBM11023
- KBio1_001421
- KBio2_001396
- KBio2_002278
- KBio2_003964
- KBio2_004846
- KBio2_006532
- KBio2_007414
- KBio3_001689
- KBio3_001842
- Methyl-carbamic acid, ester with eseroline
- CID5983
- ESERINE (REFERENCE GRADE)
- Eserolein,methylcarbamate (ester)
- CS 58525
- HMS1921G06
- HMS2089M11
- HMS2236L08
- HMS3261B07
- Carbamic acid, methyl-, ester with eseroline
- BCP19735
- Carbamic acid, ester with eseroline
- CID:5983
- HY-N6608
- MSK40315
- (3aS,8aR)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indol-5-yl methylcarbamate
- PHYSOSTIGMINE [USP IMPURITY]
- Tox21_111228
- Tox21_301591
- Tox21_500483
- BDBM50004000
- BDBM50222010
- CCG-38605
- EBC-26402
- MFCD00151090
- NCGC00093889-03
- NIH-10421
- ZINC91689892
- AKOS016843649
- C15-H21-N3-O2
- Tox21_111228_1
- CS-O-11713
- DB00981
- FE59473
- J4.579I
- LP00483
- RP29728
- SDCCGMLS-0066585.P001
- SDCCGSBI-0050467.P005
- CAS-57-47-6
- NCGC00093889-01
- NCGC00093889-02
- NCGC00093889-04
- NCGC00093889-05
- NCGC00093889-06
- NCGC00093889-07
- NCGC00093889-08
- NCGC00093889-09
- NCGC00093889-10
- NCGC00093889-12
- NCGC00093889-13
- NCGC00093889-20
- NCGC00255345-01
- NCGC00261168-01
- AC-15983
- AC-37456
- AJ-86526
- DA-56831
- SID:53787117
- SMR000718753
- SBI-0050467.P004
- LS-109562
- Physostigmine (buccal, xerostomia), Calabar
- CS-0034353
- EU-0100483
- NS00004015
- P0406
- Physostigmine (local acting gel, xerostomia)
- Physostigmine 100 microg/mL in Acetonitrile
- C06535
- D00196
- E 8375
- G60920
- A964564
- D010830
- EN300-23839407
- Q410595
- SR-01000075341
- Acetylcholinesterase inhibitor (dry mouth), Calabar
- Eserine; Antilirium; Physostol; Esromiotin; Ezerin
- Pyrrolo(2,3-b)indol-5-ol, 1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethyl-, methylcarbamate (ester), (3aS-cis)-
- SR-01000075341-1
- WLN: T B556 EN GNTT&J B1 E1 G1 KOVM1
- BRD-K25650355-001-02-5
- BRD-K25650355-059-02-3
- BRD-K25650355-059-12-2
- BRD-K25650355-059-18-9
- BRD-K25650355-065-02-0
- Physostigmine (local acting gel, xerostomia), Calabar
- (3aS-cis)-1,2,3,3a,8,8a-Hexahydro-1,3a,8-trimethylpyrrolo(2,3-b)indol-5-ol methylcarbamate (ester)
- (3aS,8aR)-1,3a,8-trimethyl-1H,2H,3H,3aH,8H,8aH-pyrrolo[2,3-b]indol-5-yl N-methylcarbamate
- [(3aR,8bS)-3,4,8b-trimethyl-2,3a-dihydro-1H-pyrrolo[2,3-b]indol-7-yl] N-methylcarbamate
- 1,2,3,3abeta,8abeta-Hexahydro-1,3a,8-trimethylpyrrolo(2,3-b)-indol-5-yl methylcarbamate
- Pyrrolo(2,3-b)indol-5-ol, 1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethyl-, methylcarbamate (ester), (3aS-cis)
- Pyrrolo(2,3-b)indol-5-ol, 1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethyl-, methylcarbamate (ester), (3aS,8aR)-
- ((3aR,8bS)-3,4,8b-trimethyl-2,3a-dihydro-1H-pyrrolo(2,3-b)indol-7-yl) N-methylcarbamate
- (2R)-1,3-Dimethyl-2beta,3beta-(methyliminoethylene)-5-(methylcarbamoyloxy)indoline
- (3aS,8aR)-1,3a,8-Trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indol-5-yl hydrogen methylcarbonimidate
- (3aS,8aR)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indol-5-yl methylcarbamate hydrochloride
- (3aS,8aR)-1,3a,8-Trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indol-5-ylmethylcarbamate
- (3aS,8aR)-1,3a,8-trimethyl-1H,2H,3H,3aH,8H,8aH-pyrrolo(2,3-b)indol-5-yl N-methylcarbamate
- (3aS,8aR)-1,3a,8-trimethyl-1H,2H,3H,3aH,8H,8aH-pyrrolo[2,3-b]indol-5-yl N-methylcarbamate; 2-hydroxybenzoic acid
- (3aS-cis)-1,2,3,3a,8,8a-Hexahydro-1,3a,8-trimethylpyrrolo[2,3-b]indol-5-ol methylcarba-mate (ester)
- 1,2,3,3A.BETA.,8A.BETA.-HEXAHYDRO-1,3A,8-TRIMETHYLPYRROLO(2,3-B)-INDOL-5-YL METHYLCARBAMATE
- 200-332-8
- 64-47-1
- Eserine; Physostigmine (8CI); Pyrrolo[2,3-b]indol-5-ol, 1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethyl-, methylcarbamate (ester), (3aS,8aR)- (9CI); Pyrrolo[2,3-b]indol-5-ol, 1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethyl-, methylcarbamate (ester), (3aS-cis)-; (-)-Eserine; (-)-Physostigmine; Cogmine; Eserine; Esromiotin; MCV 4484; NIH 10421; NSC 30782; Physostol; Pyrrolo[2,3-b]indol-5-ol, 1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethyl-, 5-(N-methylcarbamate), (3aS,8aR)-
- Methylcarbamic acid (1,3aalpha,8-trimethyl-1,2,3,3a,8,8aalpha-hexahydropyrrolo[2,3-b]indole-5-yl) ester
- Methylcarbamic acid (3aS)-1,2,3,3a,8,8aalpha-hexahydro-1,3aalpha,8-trimethylpyrrolo[2,3-b]indol-5-yl ester
- Methylcarbamic acid (3aS)-1,2,3,3aalpha,8,8aalpha-hexahydro-1,3a,8-trimethylpyrrolo[2,3-b]indol-5-yl ester
- Methylcarbamic acid (3aS)-1,2,3,3aalpha,8,8aalpha-hexahydro-1,3aalpha,8-trimethylpyrrolo[2,3-b]indol-5-yl
- Methylcarbamic acid (3aS,8aR)-1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethylpyrrolo[2,3-b]indole-5-yl ester
- Methylcarbamic acid 1,2,3,3a,8,8aalpha-hexahydro-1,3aalpha,8-trimethylpyrrolo[2,3-b]indole-5-yl ester
- Pyrrolo(2,3-b)indol-5-ol, 1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethyl-, 5-(N-methylcarbamate), (3aS,8aR)-
- Pyrrolo[2, 1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethyl-, methylcarbamate (ester), (3aS-cis)-
- Pyrrolo[2,3-b]indol-5-ol, 1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethyl-, methylcarbamate (ester), (3aS,8aR)-
- Pyrrolo[2,3-b]indol-5-ol, 1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethyl-, methylcarbamate (ester), (3aS-cis)-